Stockscreener 앱 받기
0.795
2.58%
0.02
시장 영업 전:
.80
0.005
+0.63%
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
Volume spikes in XORTX Therapeutics Inc. stock – what they meanSector-Wise Equity Performance Trend Forecast - Newser
Using fundamentals and technicals on XORTX Therapeutics Inc.Real Stock Picks With Setup Verification - Newser
Custom watchlist performance reports with XORTX Therapeutics Inc.Weekly Setup Summary for Risk Controlled Trades - Newser
Breakout Traders Target XORTX Therapeutics Inc. on Recovery SetupDaily Volume Spike Trading Signals Detected - metal.it
What Fibonacci levels say about XORTX Therapeutics Inc. reboundMarket Liquidity and Price Flow Analysis - Newser
Should you hold or exit XORTX Therapeutics Inc. nowChart Driven Entry Timing for Swing Trades - Newser
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs - MSN
How XORTX Therapeutics Inc. stock performs during market volatilitySafe Investment Ideas with Growth Upside - Newser
Is XORTX Therapeutics Inc. stock poised for growthReversal Pattern Insights with Entry Tips - Newser
Leading vs lagging indicators on XORTX Therapeutics Inc. performanceFree Entry Alert Based on Volume Spikes - Newser
Is XORTX Therapeutics Inc. stock overhyped or has real potentialFree Breakout Entry Signal Confirmation Tool - Newser
Combining price and volume data for XORTX Therapeutics Inc.Earnings Based Stock Performance Forecast - Newser
Using R and stats models for XORTX Therapeutics Inc. forecastingFree Consistent Income Focused Trade List - Newser
Sector ETF performance correlation with XORTX Therapeutics Inc.Momentum Trading Guide with Safety Limits - Newser
XORTX Completes USD $114,500 Private Placement - GlobeNewswire
XORTX Completes USD $114,500 Private Placement - GlobeNewswire Inc.
How sentiment analysis helps forecast XORTX Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser
Smart tools for monitoring XORTX Therapeutics Inc.’s price actionFast Return Equity Forecast With Logic - Newser
Xortx Therapeutics announces planned goals for 2026 - TipRanks
XORTX Therapeutics Advances Gout Program with Strategic 2025/2026 Goals - TipRanks
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026 - GlobeNewswire
Chart overlay techniques for tracking XORTX Therapeutics Inc.Momentum Screener with Buy and Sell Areas - Newser
Is this a good reentry point in XORTX Therapeutics Inc.Momentum Stocks with Breakout Potential - Newser
Will XORTX Therapeutics Inc. continue its uptrendSmart Chart Forecasting with AI Algorithms - Newser
Can technical indicators confirm XORTX Therapeutics Inc.’s reversalConsistent Profit Signals with AI Models - Newser
Will earnings trigger a reversal in XORTX Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser
Recovery Setup Building in XORTX Therapeutics Inc. Experts SayWeekly Watchlist of High Movers Released - beatles.ru
XORTX Therapeutics Inc. stock retracement – recovery analysisIntraday Price Forecast Using Volume Models - Newser
Bull of the Day: Netflix, Inc. (NFLX) - The Globe and Mail
XORTX Therapeutics Inc. stock chart pattern explainedSafe Entry Screening with Data Backed Analysis - Newser
McEwen Q2 2025 Results Conference Call - The Globe and Mail
Baker Hughes & Chart Ink $13.6B Deal—Start of Energy's Comeback? - The Globe and Mail
Moody’s Corporation to Present at the Oppenheimer Annual Technology, Internet & Communications Conference on August 11, 2025 - The Globe and Mail
0.24%
3.39%
자본화:
|
볼륨(24시간):